Indeed, Gerenu and colleagues demonstrated in both a clinical and experimental model of AD that the soluble form of Aβ affects the proteolytic cleavage of pro-BDNF, suggesting that alterations in BDNF maturation can contribute to neuronal and cognitive dysfunctions [159] (Figure 1). This evidence concerns the gene BDNF and Alzheimer disease.